These results suggested thatmiR122-silenced HCC cells were more resistant to sorafenib because theycontained higher intracellular arginine and NO levels, possibly through elevatedexpression of SLC7A1, an arginine transporter and a target of miR122. Here, SLC7A1 is linked to hepatocellular carcinoma.